Sushant Singh
CEO
Vrit Inc
Sushant Singh, PhD is Chief Executive Officer and Co-Founder of VRiT Inc., a Toronto based regenerative medicine company developing a handheld bioprinting platform, INSITE™, that eliminates the need for autografts in the treatment of severe skin wounds. Under his strategic leadership, VRiT won the top overall prize at the University of Toronto’s 2026 Desjardins Startup Prize and was named to BetaKit’s second annual list of Canada’s Most Ambitious Companies. The company’s work spans civilian and defence-related medicine.
Schedule
Rocket Pitches: University of Toronto
Get a glimpse at the early-stage startups that will be making headlines and raising funding in the months and years ahead. This showcase will feature some of the most promising ventures from across the University of Toronto in areas including bioprinting, AI powered translation solutions, superconductors, organic waste processing, and data intelligence. Get to know these companies before your competitors do!